We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 192

No Approval for Generic Product for Treatment of Rosacea
  • McDermott Will & Emery
  • USA
  • June 28 2016

Addressing infringement under the doctrine of equivalents and obviousness issues, the US Court of Appeals for the Federal Circuit affirmed the


Federal Circuit upholds ITC’s authority to enforce consent order covering third-party products
  • McDermott Will & Emery
  • USA
  • October 29 2014

The U.S. Court of Appeals for the Federal Circuit affirmed in part and reversed in part a decision of the International Trade Commission (ITC, the


Cross Match Technologies files appeal with Federal Circuit in biometric scanning devices investigation
  • McDermott Will & Emery
  • USA
  • October 21 2011

On October 18, complainant Cross Match Technologies filed a notice of appeal with the Federal Circuit of the Commission's decision in Inv. No. 337-TA-720, Certain Biometric Scanning Devices, Components Thereof, Associated Software, and Products Containing the Same


Federal Circuit Rejects ITC’s Authority over Intangible Articles
  • McDermott Will & Emery
  • USA
  • April 28 2016

The US Court of Appeals for the Federal Circuit denied a request for rehearing en banc in ClearCorrect Operating v. Int'l Trade Comm'n, (IP Update


Federal Circuit ruling clears way for approval of generic version of Fentora
  • McDermott Will & Emery
  • USA
  • March 29 2013

Addressing allegations of patent infringement by a generic version of Fentora, the U.S. Court of Appeals for the Federal Circuit reversed in


Generics challenge to Crestor patent fails
  • McDermott Will & Emery
  • USA
  • January 31 2013

In a case involving multiple defendants seeking to sell generic versions of the drug rosuvastatin calcium, currently marketed as Crestor, the U


Wrongful injunction raises presumption of recovery of bond
  • McDermott Will & Emery
  • USA
  • June 30 2011

In a case of first impression, the U.S. Court of Appeals for the Second Circuit ruled that wrongfully enjoined parties are entitled to a presumption in favor of recovery against an injunction bond for provable damages


Obviousness-type double patenting requires a reason to modify with a reasonable expectation of success
  • McDermott Will & Emery
  • USA
  • October 31 2012

Addressing the issue of obviousness-type double patenting, the U.S. Court of Appeals for the Federal Circuit reaffirmed its earlier rulings that obviousness must be judged by whether the differences in subject matter between the new claim and the earlier claim are patentably distinct


International Trade Commission addresses use of standard-essential patents in Section 337 investigations
  • McDermott Will & Emery
  • USA
  • July 31 2013

The International Trade Commission (ITC) addressed for the first time the issue of whether infringement of a patent that has previously been declared


“Clear and convincing” is the standard for obviousness no matter what
  • McDermott Will & Emery
  • USA
  • July 31 2012

Clarifying the standards and burdens associated with an obviousness analysis, the U.S. Court of Appeals for the Federal Circuit found that the presumption of validity and burden of proving obviousness do not change regardless of the facts of a particular case